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The still increasing global migration affects the epidemiology of tuberculosis (TB) in European countries.
We present the case of an asylum seeker from a TB high-endemic country, who presented with severe TB
spondylodiscitis and need for emergency surgery. The patient had a history of recurrent sterile axillary
and perianal abscesses for years, but TB was never properly ruled out. The patient underwent surgery,
responded well to antibiotics and regained the ability to walk. After 6 month of treatment the patient
was lost to follow-up. In light of the increasing migration from TB high-endemic countries to low-
endemic countries, this case illustrates the paramount importance of minding TB as a differential
diagnosis.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tuberculous spondylodiscitis accounts for <5% of all tubercu-
losis (TB) cases and is a rare but extremely serious clinical condi-
tion, which, if undiagnosed, can lead to compression of medulla
causing severe and disabling neurological sequela [1].
We present the case of an asylum seeker living in a refugee
camp, who had a history of recurrent axillary and perianal ab-
scesses for years, before eventually presenting with cauda equina
syndrome, severe TB spondylodiscitis and need for emergency
surgery.
In light of the increasing migration from TB high-endemic
countries to low-endemic countries, this case illustrates the para-
mount importance of minding TB as a differential diagnosis.2. Case presentation
A 40-something-year-old asylum seeker originating from a TB
high-endemic country, staying in a refugee camp in Denmark for 8
years with no recent travel history, was admitted to the emergency
department complaining of 3 days of severe pain in the lowerry and Infectious Diseases,
d, Denmark.
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located to the lower limbs was noted and ability to walk was
slightly impaired. After pain relief the patient appeared unaffected
and was found neurologically intact. There was no history of
coughing, fevers, night sweat, fatigue or weight loss. Laboratory
tests revealed slightly elevated inﬂammatory markers. HIV test was
negative. Chest radiography was normal. A computed tomography
(CT) of the spine showed a local destruction in vertebrae L4 with
surrounding soft tissue involvement suspicious for spondylodisci-
tis. While awaiting a magnetic resonance imaging (MRI), the pa-
tient developed perianal and saddle numbness, decreased anal
tone, urinary retention and lost the ability to walk. Acute MRI
showed spondylodiscitis with an abscess at L4, inﬂammation
reaching into the psoas and backmuscles and dura compressed and
dislocated consistent with cauda equina syndrome. Emergency
surgical decompression revealed an intraspinal abscess containing
caseous material. Histopathology detected necrotizing granulo-
matous inﬂammation, no acid-fast bacilli (AFB) and no signs of
malignancy. Standard microscopy and culture of pus were without
microorganisms. Empirical standard anti-TB regimen (isoniazid,
ethambutol, pyrazinamide and rifampicin) was initiated. Due to the
possibility of multidrug resistant TB (MDR-TB), moxiﬂoxacin was
added. Microscopy for AFB and PCR for Mycobacterium tuberculosis
(MTB) were negative. After 30 days fully susceptible MTB were
grown from the bone biopsy. Thereafter, moxiﬂoxacin was dis-
continued. The patient tolerated the treatment well, slowlynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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months of treatment, the patient slowly regained the ability towalk
without support, but the paraesthesia persisted. The patient was
lost to follow-up after 6 month of treatment and has left the
country.
The patient had a history of several hospitalizations with
recurrent sterile abscesses prior to this emergency situation; A
perianal abscess had been removed 7 years prior and a perianal and
an axillary abscess had been surgical drained 2 years prior. At both
occasions standard microscopy and culture of pus had been nega-
tive. No materiel had been sent for speciﬁc mycobacterial micro-
scopy, PCR or culture. At the last contact a QuantiFERON-TB (QFT))
test was performed and found positive, a chest radiography was
normal, however, no further diagnostic tests for TB were performed
and no further follow up was planned.
3. Discussion
TB remains one of the most widespread infectious diseases in
the world, mostly in low-income countries. The still increasing
global migration from TB high-endemic countries is affecting the
epidemiology of TB in low-endemic countries [2]. In Scandinavia
approximately 70% of new TB cases occur in immigrants from TB
high-endemic countries and the majority are infected in their
country of origin [3]. Pulmonary TB is the most frequent manifes-
tation, however extrapulmonary TB is common among people from
TB high-endemic countries and a high level of medical awareness
must be encouraged [4]. Spinal- and perianal TB are rare manifes-
tations of TB and in line with our ﬁndings a diagnostic delay is
frequently reported in patients with abscesses [5,6]. Due to our
patient's history of recurrent “sterile” abscesses and the subsequent
diagnosis of spinal TB we strongly suspect that the recurrent ab-
scesses were due to MTB. Thus TB could potentially have been
diagnosed earlier.
Since 2014, many Western European countries have experi-
enced an increase inmigrants and refugees, which poses challenges
for the control of TB [2]. This case illustrates the challenges of TB
diagnostic in refugees from high-endemic countries: In the low-
endemic Western countries, TB is forgotten by many clinical spe-
cialists and is not considered as differential diagnosis [7]. Refugees
are considered at increased risk of developing TB due to malnu-
trition, stress from long journeys, staying in areas of conﬂict and
war, crowded refugee camps and the lack of access to healthcare
and there can be several barriers to timely diagnosis of TB among
refugees such as language, social barriers and a fear of stigmatisa-
tion [8]. Authorities, as well as medical personal, and personal at
refugees' camps must be aware of these barriers in order to prevent
delays in TB diagnostic and treatment. Furthermore healthcare
systems and personnel should be aware of the health conditions
and diseases that might follow these population groups and be
adjusted accordingly.
In Denmark, unlike other Scandinavian and most Western Eu-
ropean countries, mandatory screening for active TB among asylum
seekers at arrival to the country has not yet been implemented.
Optimally, the policy of TB screening upon arrival should be theDownloaded for Anonymous User (n/a) at BS - University of Cop
For personal use only. No other uses without permissionsame for all European countries, but for now signiﬁcant different
screening practices exist among countries [9]. Systematic screening
for TB among migrants/refugees from TB high-endemic countries
may help to timely identify and treat people with active TB disease.
This will beneﬁt not only a single person (by treating the disease),
but also the general population e by preventing further spread of
the infection. Furthermore when we screen for TB among a highly
vulnerable group as refugees, we need an adequate and reasonable
follow-up plan, which has appeared to be a major challenge [9]
especially regarding insufﬁcient tracking [7]. However, while the
debate on cost-effectiveness of different screening approaches and
follow-ups are on-going [10], we need to underline for clinicians
and other medical personnel the importance of considering TB as a
differential diagnosis among migrants.Funding
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